Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates t...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Oh, Se-Woong Kim, Kyeong Bae Oh, Sang Ho Shin, Woo Seob Ju, Hyun Kim, Dong Kyun Kim, Jong Gyun Park, Su Min Han, Tae Dong Lee, Young Sung Kang, Jeong Ki Chung, Soo Yong Lee, Seong Ran |
description | The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11453656B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11453656B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11453656B23</originalsourceid><addsrcrecordid>eNqNykEKwjAQheFuXIh6h3Gvi1rtARTFfXVdhmSigWQmTGKht7cFD-DqPfi_ZcUdhgLiABkwepY0qreeCSypH7D4gcBITPJhuwMEo2MuGMJMnGiE8iYlcVNjO_WkYijnuU2fEqrn14wgY6R1tXAYMm1-u6q2t-vjct9Tkp5yQkNMpX92dX08Ne2pPR-af8wXkulCXA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same</title><source>esp@cenet</source><creator>Oh, Se-Woong ; Kim, Kyeong Bae ; Oh, Sang Ho ; Shin, Woo Seob ; Ju, Hyun ; Kim, Dong Kyun ; Kim, Jong Gyun ; Park, Su Min ; Han, Tae Dong ; Lee, Young Sung ; Kang, Jeong Ki ; Chung, Soo Yong ; Lee, Seong Ran</creator><creatorcontrib>Oh, Se-Woong ; Kim, Kyeong Bae ; Oh, Sang Ho ; Shin, Woo Seob ; Ju, Hyun ; Kim, Dong Kyun ; Kim, Jong Gyun ; Park, Su Min ; Han, Tae Dong ; Lee, Young Sung ; Kang, Jeong Ki ; Chung, Soo Yong ; Lee, Seong Ran</creatorcontrib><description>The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220927&DB=EPODOC&CC=US&NR=11453656B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220927&DB=EPODOC&CC=US&NR=11453656B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Oh, Se-Woong</creatorcontrib><creatorcontrib>Kim, Kyeong Bae</creatorcontrib><creatorcontrib>Oh, Sang Ho</creatorcontrib><creatorcontrib>Shin, Woo Seob</creatorcontrib><creatorcontrib>Ju, Hyun</creatorcontrib><creatorcontrib>Kim, Dong Kyun</creatorcontrib><creatorcontrib>Kim, Jong Gyun</creatorcontrib><creatorcontrib>Park, Su Min</creatorcontrib><creatorcontrib>Han, Tae Dong</creatorcontrib><creatorcontrib>Lee, Young Sung</creatorcontrib><creatorcontrib>Kang, Jeong Ki</creatorcontrib><creatorcontrib>Chung, Soo Yong</creatorcontrib><creatorcontrib>Lee, Seong Ran</creatorcontrib><title>Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same</title><description>The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKwjAQheFuXIh6h3Gvi1rtARTFfXVdhmSigWQmTGKht7cFD-DqPfi_ZcUdhgLiABkwepY0qreeCSypH7D4gcBITPJhuwMEo2MuGMJMnGiE8iYlcVNjO_WkYijnuU2fEqrn14wgY6R1tXAYMm1-u6q2t-vjct9Tkp5yQkNMpX92dX08Ne2pPR-af8wXkulCXA</recordid><startdate>20220927</startdate><enddate>20220927</enddate><creator>Oh, Se-Woong</creator><creator>Kim, Kyeong Bae</creator><creator>Oh, Sang Ho</creator><creator>Shin, Woo Seob</creator><creator>Ju, Hyun</creator><creator>Kim, Dong Kyun</creator><creator>Kim, Jong Gyun</creator><creator>Park, Su Min</creator><creator>Han, Tae Dong</creator><creator>Lee, Young Sung</creator><creator>Kang, Jeong Ki</creator><creator>Chung, Soo Yong</creator><creator>Lee, Seong Ran</creator><scope>EVB</scope></search><sort><creationdate>20220927</creationdate><title>Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same</title><author>Oh, Se-Woong ; Kim, Kyeong Bae ; Oh, Sang Ho ; Shin, Woo Seob ; Ju, Hyun ; Kim, Dong Kyun ; Kim, Jong Gyun ; Park, Su Min ; Han, Tae Dong ; Lee, Young Sung ; Kang, Jeong Ki ; Chung, Soo Yong ; Lee, Seong Ran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11453656B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Oh, Se-Woong</creatorcontrib><creatorcontrib>Kim, Kyeong Bae</creatorcontrib><creatorcontrib>Oh, Sang Ho</creatorcontrib><creatorcontrib>Shin, Woo Seob</creatorcontrib><creatorcontrib>Ju, Hyun</creatorcontrib><creatorcontrib>Kim, Dong Kyun</creatorcontrib><creatorcontrib>Kim, Jong Gyun</creatorcontrib><creatorcontrib>Park, Su Min</creatorcontrib><creatorcontrib>Han, Tae Dong</creatorcontrib><creatorcontrib>Lee, Young Sung</creatorcontrib><creatorcontrib>Kang, Jeong Ki</creatorcontrib><creatorcontrib>Chung, Soo Yong</creatorcontrib><creatorcontrib>Lee, Seong Ran</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Oh, Se-Woong</au><au>Kim, Kyeong Bae</au><au>Oh, Sang Ho</au><au>Shin, Woo Seob</au><au>Ju, Hyun</au><au>Kim, Dong Kyun</au><au>Kim, Jong Gyun</au><au>Park, Su Min</au><au>Han, Tae Dong</au><au>Lee, Young Sung</au><au>Kang, Jeong Ki</au><au>Chung, Soo Yong</au><au>Lee, Seong Ran</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same</title><date>2022-09-27</date><risdate>2022</risdate><abstract>The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US11453656B2 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A30%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Oh,%20Se-Woong&rft.date=2022-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11453656B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |